CN108785365A - A kind of eyedrops for treating myopia - Google Patents
A kind of eyedrops for treating myopia Download PDFInfo
- Publication number
- CN108785365A CN108785365A CN201810838662.4A CN201810838662A CN108785365A CN 108785365 A CN108785365 A CN 108785365A CN 201810838662 A CN201810838662 A CN 201810838662A CN 108785365 A CN108785365 A CN 108785365A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- eyedrops
- powder
- myopia
- honeysuckle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of eyedrops for treating myopia, includes the raw material of following parts by weight:Bear gall powder 5-15, Fel Serpentis powder 5-15, chamomile 100-150, honeysuckle 90-110, cassia seed 90-110, vitamin B 100-150, vitamin C 50-70, borneol 5-15, sodium chloride 5-15.Treatment of the eyedrops of the present invention for myopia, adheres to Chinese medicine theory, does not operate on, is not moulding, do not have an injection, do not take medicine, safety and stability.The present invention overcomes drug therapy be susceptible to side effect, the defect easily recurred, operative treatment there are risk and sequelae, wear optical glasses can only solve visual impairment patient it is daily regard object but it is palliative the problems such as, using pure natural raw material, reasonable compatibility, synergistic effect, develop into safe efficient, high quality product, the significant effect of myopia is treated, safely and effectively.
Description
Technical field
The invention belongs to field of medicaments, and in particular to a kind of eyedrops for treating myopia.
Background technology
It is referred to as near-sighted before parallel rays focuses on retina after eye refraction system in the state that adjusting is loosened.
Myopia is also referred to as short-sighted eye, cannot closely be seen far because this eye can only be seen.
World Health Organization's research report claims, at present China's A nearsighted person's number up to 600,000,000!High school student and university student's is close
Depending on rate more than 7 one-tenth, and increase year by year, adolescent myopia rate height ranks first in the world, and the rate of myopia of pupil is also close to 40%.
It, will be close to 7.04 to 7.11 hundred million to the year two thousand twenty China myopia illness population according to conservative estimation.Myopia therapeutic method has medicine at present
Object treatment, operative treatment and other treatment:Drug therapy type is various, including atropine, neostigmine, Tropicamide etc., but
There are certain side effect and easily recurrence.Operative treatment is there are risk and has sequelae;Other treatment is as worn optical glasses but only
It can solve the problems, such as that visual impairment patient's is daily regarding object, it is palliative.
Therefore, how myopia is treated, becomes a real project.
Invention content
The purpose of the present invention is intended to provide a kind of eyedrops for treating myopia, passes on Chinese medicine theory, treats myopia effect
Fruit is notable.
To achieve the above object, the eyedrops for treating myopia of the invention, includes the raw material of following parts by weight:Bear gall
Powder 5-15, Fel Serpentis powder 5-15, chamomile 100-150, honeysuckle 90-110, cassia seed 90-110, vitamin B 100-150, dimension
Raw element C 50-70, borneol 5-15, sodium chloride 5-15.
Preferably, include the raw material of following parts by weight:Bear gall powder 5, Fel Serpentis powder 5, chamomile 100, honeysuckle 90, cassia seed
90, vitamin B 100, vitamin C 50, borneol 5, sodium chloride 5.
Preferably, include the raw material of following parts by weight:Bear gall powder 10, chamomile 120, honeysuckle 100, is determined at Fel Serpentis powder 10
Pine torch 100, vitamin B 120, vitamin C 60, borneol 10, sodium chloride 10.
Preferably, include the raw material of following parts by weight:Bear gall powder 15, chamomile 150, honeysuckle 110, is determined at Fel Serpentis powder 15
Pine torch 110, vitamin B 150, vitamin C 70, borneol 15, sodium chloride 15.
Further, the present invention is used to treat the preparation method of the eyedrops of myopia, and steps are as follows:
1)Chamomile, honeysuckle, cassia seed are incorporated in the marmite of water, is cooked by slow fire 4-6 hours, filtrate is collected by filtration after cooling
It is spare;
2)Bear gall powder, Fel Serpentis powder, vitamin B, vitamin C is added in filtrate in step 1, adds borneol, sodium chloride, is stirred
It after uniformly, sterilizes, is dispensed up to eyedrops after adjusting pH to 6-7.
Primary raw material is illustrated below:
Bear gall powder, heat-clearing, soothing the liver, improving eyesight.For red eye, swell pain, abscess of throat.
Fel Serpentis powder, snake gall are the gall-bladders of storage bile in snake body.Snake gall is cool in nature, bitter but slightly sweet taste;With dispelling wind and eliminating dampness, refrigerant
The effect of miliaria is removed in improving eyesight, removing toxic substances;The adjustable nervous system for mending people, internal system and immune system, delay body aging.
Irascibility is moved back in chamomile, mildly bitter flavor, Gan Xiang, improving eyesight, and treatment insomnia reduces blood pressure, can invigorate, refresh oneself, relaxes
Solve eye fatigue.
Honeysuckle, effect is mainly clearing heat and detoxicating, cures mainly warm disease heating, toxic-heat and blood stasis, ulcer serious case of furuncle etc..Modern study
It proves, honeysuckle contains the pharmacological components such as chlorogenic acid, cyanidenon glycosides, to hemolytic streptococcus, Staphylococcus aureus etc.
Various pathogens and infection of the upper respiratory tract Causative virus etc. have stronger restraint, in addition can also strengthen immunity, Robust speaker feature, shield
Liver, antitumor, anti-inflammatory, antipyretic, hemostasis(Blood coagulation), inhibit intestinal absorption cholesterol etc., clinical application is very extensive, can be with it
Its compatibility of drugs plants illness for treating respiratory tract infection, bacillary dysentery, acute urinary, hypertension etc. more than 40.Through informal dress
Impregnated with honeysuckle or decoction be conducive to the treatment of wind fire hot eyes, abscess of throat, obesity, liver heat symptom-complex and liver heat type hypertension with
Rehabilitation.
Cassia seed, cassia seed bitter, sweet, salty, cold nature enters liver, kidney, large intestine channel;It relaxes bowel, lipid-loweringing improving eyesight, treatment
Constipation and hyperlipidemia, hypertension.
Borneol through steam distillation and is recrystallized and is obtained by composite family Blumea balsamifera cauline leaf or canella borneol camphor tree branches and leaves,
Also useful turpentine oil is obtained through a series of chemical method techniques.It can be used for closing card coma, is used for red eye, swell pain, larynx numbness aphtha,
For sore swell and ache curative, do not held back after bursting.
The present invention substantive distinguishing features and marked improvement be:
Treatment of the eyedrops of the present invention for myopia, adheres to Chinese medicine theory, does not operate on, is not moulding, do not have an injection, do not take medicine, safety
Stablize.Side effect, the defect easily recurred, operative treatment are susceptible to there are risk the present invention overcomes drug therapy and rear are lost
Disease, wear optical glasses can only solve visual impairment patient it is daily regard object but it is palliative the problems such as, using pure natural original
Material, reasonable compatibility, synergistic effect, exploitation are treated the significant effect of myopia, are had safely at safe efficient, high quality product
Effect.
Specific implementation mode
The technical solution further illustrated the present invention below by specific embodiment.
Embodiment 1
The eyedrops for treating myopia of the present invention, includes the raw material of following parts by weight:Bear gall powder 5, Fel Serpentis powder 5, chamomile
100, honeysuckle 90, cassia seed 90, vitamin B 100, vitamin C 50, borneol 5, sodium chloride 5.
The present invention is used to treat the preparation method of the eyedrops of myopia, and steps are as follows:
1)Chamomile, honeysuckle, cassia seed are incorporated in the marmite of water, is cooked by slow fire 4-6 hours, filtrate is collected by filtration after cooling
It is spare;
2)Bear gall powder, Fel Serpentis powder, vitamin B, vitamin C is added in filtrate in step 1, adds borneol, sodium chloride, is stirred
It after uniformly, sterilizes, is dispensed up to eyedrops after adjusting pH to 6-7.
Embodiment 2
The eyedrops for treating myopia of the present invention, includes the raw material of following parts by weight:Bear gall powder 10, Fel Serpentis powder 10, ocean are sweet
Chrysanthemum 120, honeysuckle 100, cassia seed 100, vitamin B 120, vitamin C 60, borneol 10, sodium chloride 10.
The present invention is used to treat the preparation method of the eyedrops of myopia, and steps are as follows:
1)Chamomile, honeysuckle, cassia seed are incorporated in the marmite of water, is cooked by slow fire 4-6 hours, filtrate is collected by filtration after cooling
It is spare;
2)Bear gall powder, Fel Serpentis powder, vitamin B, vitamin C is added in filtrate in step 1, adds borneol, sodium chloride, is stirred
It after uniformly, sterilizes, is dispensed up to eyedrops after adjusting pH to 6-7.
Embodiment 3
The eyedrops for treating myopia of the present invention, includes the raw material of following parts by weight:Bear gall powder 15, Fel Serpentis powder 15, ocean are sweet
Chrysanthemum 150, honeysuckle 110, cassia seed 110, vitamin B 150, vitamin C 70, borneol 15, sodium chloride 15.
The present invention is used to treat the preparation method of the eyedrops of myopia, and steps are as follows:
1)Chamomile, honeysuckle, cassia seed are incorporated in the marmite of water, is cooked by slow fire 4-6 hours, filtrate is collected by filtration after cooling
It is spare;
2)Bear gall powder, Fel Serpentis powder, vitamin B, vitamin C is added in filtrate in step 1, adds borneol, sodium chloride, is stirred
It after uniformly, sterilizes, is dispensed up to eyedrops after adjusting pH to 6-7.
Eyedrops of the present invention passes on Chinese medicine theory, treats near-sighted significant effect, safely and effectively.
Claims (5)
1. a kind of eyedrops for treating myopia, which is characterized in that include the raw material of following parts by weight:Bear gall powder 5-15, snake
Courage powder 5-15, chamomile 100-150, honeysuckle 90-110, cassia seed 90-110, vitamin B 100-150, vitamin C 50-
70, borneol 5-15, sodium chloride 5-15.
2. the eyedrops according to claim 1 for treating myopia, it is characterised in that:Include the original of following parts by weight
Material:Bear gall powder 5, Fel Serpentis powder 5, chamomile 100, honeysuckle 90, cassia seed 90, vitamin B 100, vitamin C 50, borneol 5,
Sodium chloride 5.
3. the eyedrops according to claim 1 for treating myopia, it is characterised in that:Include the original of following parts by weight
Material:Bear gall powder 10, Fel Serpentis powder 10, chamomile 120, honeysuckle 100, cassia seed 100, vitamin B 120, vitamin C 60, ice
Piece 10, sodium chloride 10.
4. the eyedrops according to claim 1 for treating myopia, it is characterised in that:Include the original of following parts by weight
Material:Bear gall powder 15, Fel Serpentis powder 15, chamomile 150, honeysuckle 110, cassia seed 110, vitamin B 150, vitamin C 70, ice
Piece 15, sodium chloride 15.
5. the preparation method according to claim 1 for treating the eyedrops of myopia, which is characterized in that steps are as follows:
1)Chamomile, honeysuckle, cassia seed are incorporated in the marmite of water, is cooked by slow fire 4-6 hours, filtrate is collected by filtration after cooling
It is spare;
2)Bear gall powder, Fel Serpentis powder, vitamin B, vitamin C is added in filtrate in step 1, adds borneol, sodium chloride, is stirred
It after uniformly, sterilizes, is dispensed up to eyedrops after adjusting pH to 6-7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810838662.4A CN108785365A (en) | 2018-07-27 | 2018-07-27 | A kind of eyedrops for treating myopia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810838662.4A CN108785365A (en) | 2018-07-27 | 2018-07-27 | A kind of eyedrops for treating myopia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108785365A true CN108785365A (en) | 2018-11-13 |
Family
ID=64076656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810838662.4A Pending CN108785365A (en) | 2018-07-27 | 2018-07-27 | A kind of eyedrops for treating myopia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108785365A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109908327A (en) * | 2019-03-12 | 2019-06-21 | 广州陈锦济生物科技有限公司 | It is a kind of for treating the eyedrops and preparation method thereof of myopia |
-
2018
- 2018-07-27 CN CN201810838662.4A patent/CN108785365A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109908327A (en) * | 2019-03-12 | 2019-06-21 | 广州陈锦济生物科技有限公司 | It is a kind of for treating the eyedrops and preparation method thereof of myopia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102139038A (en) | Chinese herbal preparation for treating eye diseases | |
CN107050400A (en) | Traditional Chinese medicinal liquor is smeared in one kind massage | |
CN104825801A (en) | TCM (traditional Chinese medicine) preparation for preventing and treating cardiovascular and cerebrovascular diseases | |
CN100364593C (en) | Oral liquid for promoting eyesight and protecting eye | |
CN104116900B (en) | A kind of herbal application for preventing and treating myopia and preparation method thereof | |
CN104840635A (en) | Chinese herbal medicine eye drops for relieving eyestrain and preparation method thereof | |
CN104096141A (en) | Traditional Chinese medical composition for treating allergic conjunctivitis | |
CN108785365A (en) | A kind of eyedrops for treating myopia | |
CN109700889A (en) | A kind of Chinese medicine composition and preparation method thereof of health care eyes | |
CN109908327A (en) | It is a kind of for treating the eyedrops and preparation method thereof of myopia | |
CN102283539B (en) | Medicinal pillow for preventing and treating cervical spondylosis | |
CN101112453A (en) | Chinese traditional medicine composition for treating bacchia | |
CN105194443A (en) | Traditional Chinese medicine composition for treating infantile eczema and preparation method of composition | |
CN104784517A (en) | Traditional Chinese medicine for treating nerve headache | |
CN101085234A (en) | Traditional Chinese medicine preparation for treating dizziness during menstruation | |
CN104474428A (en) | Traditional Chinese medicine preparation for treating spinal cord injury and preparation method | |
CN104137939B (en) | A kind of conjunction sprouts dispelling pathogenic wind for improving eyesight tea and production method thereof | |
CN107875297A (en) | A kind of Chinese medicine composition for treating vertigo and preparation method thereof | |
CN103735920B (en) | A kind of medicine for the treatment of hemiplegia and preparation method thereof | |
CN1166372C (en) | Formula of medicine for treating myopia and preparation process thereof | |
CN107281285A (en) | A kind of swelling and pain relieving lotion | |
CN102380041A (en) | Traditional Chinese herbal lotion preparation method for curing night sweat decubitus | |
CN100400070C (en) | Externally applied medicine for treating dermatosis and preparation method thereof | |
CN105596628A (en) | Physiotherapy water with tendon relaxing and blood circulation activating efficacy and preparation method thereof | |
CN104922454A (en) | Orally-taken medicine for treating soft tissue contusion and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |